undamentalytics Newsletter

Finnegan Paul J: insider trades

Director at 3 companies we cover. No open-market purchases and 15 sales not made under a pre-set plan, reported from July 31, 2013 to August 18, 2021.

What happened after Finnegan Paul J’s sales?

After their sales, the shares moved +20.4% against the index over 12 months on average (a negative figure means selling was the right call); 7% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Finnegan Paul J: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 15 +5.8% +7.2% 27% 6 1.99 0.10 No reliable evidence
Sales, 12 months after the report 15 +20.4% +14.2% 7% 6 4.07 0.010 Strong evidence: seller wrong
Sales, 12 months after the trade 15 +19.7% +16.7% 13% 6 3.62 0.015 Some evidence: seller wrong

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
CDW Corporation CDW —013November 21, 2013August 18, 2021
Boise Cascade Co BCC —01July 31, 2013July 31, 2013
Option Care Health, Inc. OPCH —01July 24, 2020July 24, 2020

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
August 18, 2021August 17, 2021 CDW Sale $466,788 −6.1%+0.6%−3.6%
July 24, 2020July 24, 2020 OPCH Sale $100,000,000 +11.5%+34.8%+33.5%
May 11, 2018May 9, 2018 CDW Sale $176,653 +4.7%+28.0%+29.8%
December 11, 2015December 9, 2015 CDW Sale $28,055,093 −4.1%+11.9%+16.7%
December 2, 2015November 30, 2015 CDW Sale $187,033,965 −4.0%+13.7%+13.1%
August 20, 2015August 18, 2015 CDW Sale $250,559,341 +12.2%+5.9%+7.6%
May 27, 2015May 22, 2015 CDW Sale $258,447,396 +15.1%+13.8%+15.7%
December 10, 2014December 8, 2014 CDW Sale $297,771,835 +4.0%+25.7%+29.3%
September 10, 2014September 8, 2014 CDW Sale $248,791,902 +7.2%+32.4%+28.0%
June 6, 2014June 4, 2014 CDW Sale $33,453,425 +1.6%+13.0%+12.5%
May 30, 2014May 28, 2014 CDW Sale $219,171,015 +7.6%+14.2%+15.2%
March 13, 2014March 12, 2014 CDW Sale $147,263,889 +17.6%+32.4%+28.3%
December 20, 2013December 18, 2013 CDW Sale $23,848,347 +16.5%+44.8%+39.8%
November 21, 2013November 19, 2013 CDW Sale $153,391,332 +9.0%+41.6%+38.6%
July 31, 2013July 30, 2013 BCC Sale $258,800,000 −6.3%−6.5%−9.2%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Finnegan Paul J traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.